We also found that the expression of the MUC1 gene, which is overexpressed in breast cancer patients (Appendix S1: Figure S8), and encodes the widely used CA 15‐3 (Cancer antigen 15‐3) serum biomarker for breast cancer, was significantly reduced upon SAM + 5AzadC combination treatment. Here, MUC1 is linked to breast carcinoma.